Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
FLA-ST (Standard or Ultrapure) A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... 2021 PLoS One Maguire P.M. et al. DOI: 10.1371/journal.pone.0258261
ODN 2216 - TLR9 ligand A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneu... 2021 PLoS One Maguire P.M. et al. DOI: 10.1371/journal.pone.0258261
Plasmocin® - Mycoplasma Elimination Reagent Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positiv... 2021 Commun Biol. Laliotis G.I. et al. DOI: 10.1038/s42003-021-02668-z
pFUSE-CHIg-hG1 HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheime... 2021 Commun Biol. Tanaka H. et al. DOI: 10.1038/s42003-021-02671-4
pFUSE2-CLIg-hK HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheime... 2021 Commun Biol. Tanaka H. et al. DOI: 10.1038/s42003-021-02671-4
Puromycin A role for AKT1 in nonsense-mediated mRNA decay. 2021 Nucleic Acids Res. Palma M. et al. DOI: 10.1093/nar/gkab882
pVITRO2-MCS Identification and Characterization of a Novel Single Domain Antibody Against... 2021 Virol Sin. Wang R. et al. DOI: 10.1007/s12250-021-00454-z
Poly(I:C) (HMW) VacciGrade™ A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irra... 2021 Virol J. Sabbaghi A. et al. DOI: 10.1186/s12985-021-01672-3
Anti-hTLR4-IgG The soluble cytoplasmic tail of CD45 regulates T cell activation via TLR4 sig... 2021 Eur J Immunol. Puck A. et al. DOI: 10.1002/eji.202149227
QUANTI-Blue™ Next generation of tumor-activating type I IFN enhances anti-tumor immune res... 2021 Nat Commun. Cao X. et al. DOI: 10.1038/s41467-021-26112-2
QUANTI-Luc™ Next generation of tumor-activating type I IFN enhances anti-tumor immune res... 2021 Nat Commun. Cao X. et al. DOI: 10.1038/s41467-021-26112-2
293-Dual™ hSTING-R232 Cells Next generation of tumor-activating type I IFN enhances anti-tumor immune res... 2021 Nat Commun. Cao X. et al. DOI: 10.1038/s41467-021-26112-2
CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-ne... 2021 J Exp Med Shinnakasu R. et al. DOI: 10.1084/jem.20211003
AddaVax™ Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-ne... 2021 J Exp Med Shinnakasu R. et al. DOI: 10.1084/jem.20211003
PMA Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... 2021 J Innate Immun Maruyama K. et al. DOI: 10.1159/000518953
NLRP3 KO & KD THP-1 Cells Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... 2021 J Innate Immun Maruyama K. et al. DOI: 10.1159/000518953
THP1-Null Cells Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... 2021 J Innate Immun Maruyama K. et al. DOI: 10.1159/000518953
ASC Knockout & Knockdown Monocytes Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... 2021 J Innate Immun Maruyama K. et al. DOI: 10.1159/000518953
MSU Crystals Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... 2021 J Innate Immun Maruyama K. et al. DOI: 10.1159/000518953
LPS-EK (LPS from E. coli K12) Activation of NLRP3 Inflammasome Complexes by Beta-Tricalcium Phosphate Parti... 2021 J Innate Immun Maruyama K. et al. DOI: 10.1159/000518953

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty